Distinct Lung Function Phenotypes in Never-Smokers with Chronic Airflow Limitation
Abstract Background Chronic airflow limitation (CAL) is often caused by smoking, but a proportion of subjects have never smoked. The definition of CAL is based on airway obstruction measured by spirometry, but the pathophysiology behind airway obstruction in never-smokers is poorly known. We aimed to investigate CAL (defined as FEV1/FVC < 0.7) in never-smokers employing comprehensive lung function measurements. Methods Never-smokers with CAL with FEV1/FVC < or ≥ lower limit of normal (LLN) and FEV1 < or ≥ 100% of the predicted value were included: 35 with CAL < LLN, FEV1<100 , 30 with CAL ≥ LLN, FEV1<100 , and 26 with CAL FEV1≥100 . In addition, 41 never-smokers and 23 smokers, with normal spirometry were used as controls. Pre- and postbronchodilator spirometry, respiratory oscillometry, body plethysmography and measurements of diffusing capacity were performed. Respiratory symptom burden was recorded. Results Never-smokers with CAL < LLN, FEV1<100 showed a mild lung function impairment measured by spirometry, but with lung volumes, diffusing capacity and airway resistance within normal range, and presented no increase in respiratory symptoms. They had, however, an increased bronchodilator responsiveness in airway resistance and reactance, most pronounced in the peripheral airways. In contrast, in the group with CAL FEV1≥100 , lung volumes and diffusing capacity were increased, while airway resistance was at the same level as in never-smokers without CAL. CAL ≥ LLN, FEV1<100 , presented between those with CAL < LLN, FEV1<100 and CAL FEV1≥100 . Conclusions CAL with lowered FEV1 in never-smokers constitutes a phenotype with milder lung function impairment, predominantly affecting the small airways, whereas subjects with a reduced FEV1/FVC ratio due to supranormal lungs do not have other signs of pathological lung physiology.
Authors
- Anders Blomberg (ORCID: https://orcid.org/0000-0002-2452-7347)
- Anders Andersson (ORCID: https://orcid.org/0000-0002-0934-3291)
- Åsa Maria Wheelock (ORCID: https://orcid.org/0000-0002-8013-2745)
- Annelie Behndig (ORCID: https://orcid.org/0000-0002-1533-9002)
- Andreï Malinovschi (ORCID: https://orcid.org/0000-0002-4098-7765)
- Christer Janson (ORCID: https://orcid.org/0000-0001-5093-6980)
- Leif Hilding Bjermer (ORCID: https://orcid.org/0000-0002-3441-8099)
- Jaro Ankerst (ORCID: https://orcid.org/0000-0002-0829-9129)
- Jonas Sten Erjefalt (ORCID: https://orcid.org/0000-0002-6716-3010)
- Pernilla Sönnerfors (ORCID: https://orcid.org/0000-0003-4479-3367)
- Hans Lennart Persson (ORCID: https://orcid.org/0000-0002-5700-7284)
- Finn Radner (ORCID: https://orcid.org/0000-0003-3029-5519)
- Ellen Tufvesson (ORCID: https://orcid.org/0000-0002-4941-332X)
- Petra Kristina Jacobson (ORCID: https://orcid.org/0000-0001-8550-2568)
- Abir Nasr (ORCID: https://orcid.org/0009-0000-4961-4183)
- Magnus Carl Sköld
Institutions
- Linköping University (SE)
- Uppsala University (SE)
- Karolinska University Hospital (SE)
- Lund University (SE)
- Sahlgrenska University Hospital (SE)
- Karolinska Institutet (SE)
- Umeå University (SE)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-13
- DOI
- https://doi.org/10.21203/rs.3.rs-11210834/v1
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- preprint